Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03840824 · ClinicalTrials.gov registry record
Blood Spot Self-administered Test and Assay
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 80
- Enrollment target
NCT03840824: Completed study, sponsored by University of Pennsylvania.
NCT03840824 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 80 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03840824 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
Study Summary
The current study will compare hormone levels of AMH, FSH and inhibin B in blood specimens collected by venipuncture and fingerstick in a sample of pre-menopausal women ages 18-45 years with normal menstrual cycles.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2010-10 |
| Est. Completion | 2016-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03840824
The ClinicalTrials.gov registry entry for NCT03840824 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03840824 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03840824 about?
NCT03840824 is a clinical study titled "Blood Spot Self-administered Test and Assay". The current study will compare hormone levels of AMH, FSH and inhibin B in blood specimens collected by venipuncture and fingerstick in a sample of pre-menopausal women ages 18-45 years with normal menstrual cycles.
What is the current status of trial NCT03840824?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2010-10. Estimated completion is 2016-08.
Who is sponsoring clinical trial NCT03840824?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.